DNA mutation associated with the human butyrylcholinesterase K-variant and its linkage to the atypical variant mutation and other polymorphic sites
about
Mutation at codon 322 in the human acetylcholinesterase (ACHE) gene accounts for YT blood group polymorphismChildhood brain tumors, residential insecticide exposure, and pesticide metabolism genesGenetic risk factors in Alzheimer's diseaseRivastigmine: the advantages of dual inhibition of acetylcholinesterase and butyrylcholinesterase and its role in subcortical vascular dementia and Parkinson's disease dementia.Cholinesterase variants: rapid characterisation by PCR/SSCP and evidence for molecular homogeneity.Association between butyrylcholinesterase K variant and mild cognitive impairment in the Thai community-dwelling patientsSerum cholinesterase activities distinguish between stroke patients and controls and predict 12-month mortalityUse of genetic variation as biomarkers for mild cognitive impairment and progression of mild cognitive impairment to dementia.Tetrahydrofurobenzofuran cymserine, a potent butyrylcholinesterase inhibitor and experimental Alzheimer drug candidate, enzyme kinetic analysisButyrylcholinesterase genotype and enzyme activity in relation to Gulf War illness: preliminary evidence of gene-exposure interaction from a case-control study of 1991 Gulf War veterans.Butyrylcholinesterase genetic variants: association with cocaine dependence and related phenotypes.DNA mutations associated with the human butyrylcholinesterase J-variant.Identification of two different point mutations associated with the fluoride-resistant phenotype for human butyrylcholinesterase.GWAS of butyrylcholinesterase activity identifies four novel loci, independent effects within BCHE and secondary associations with metabolic risk factorsButyrylcholinesterase K variant is genetically associated with late onset Alzheimer's disease in Northern Ireland.Rate of progression of cognitive decline in Alzheimer's disease: effect of butyrylcholinesterase K gene variationButyrylcholinesterase K variant and Alzheimer's disease risk: a meta-analysisCharacterization of 12 silent alleles of the human butyrylcholinesterase (BCHE) geneRecovery of residual curarization after red blood cell transfusion.A review of butyrylcholinesterase as a therapeutic target in the treatment of Alzheimer's disease.Naturally Occurring Genetic Variants of Human Acetylcholinesterase and Butyrylcholinesterase and Their Potential Impact on the Risk of Toxicity from Cholinesterase Inhibitors.The butyrylcholinesterase K variant confers structurally derived risks for Alzheimer pathology.High-Confidence Qualitative Identification of Organophosphorus Nerve Agent Adducts to Human Butyrylcholinesterase.Recombinant human butyrylcholinesterase as a new-age bioscavenger drug: development of the expression system.Prolonged neuromuscular blockade following succinylcholine administration to a patient with a reduced butyrylcholinesterase activity.Biochemical and genetic analysis of butyrylcholinesterase (BChE) in a family, due to prolonged neuromuscular blockade after the use of succinylcholine.A new detection method for the K variant of butyrylcholinesterase based on PCR primer introduced restriction analysis (PCR-PIRA).Butyrylcholinesterase and Acetylcholinesterase polymorphisms in Multiple Sclerosis patients: implication in peripheral inflammation.
P2860
Q24671960-79FBB689-CDCB-4C08-A46B-5DD7335DE6D4Q33522508-ED21346F-6DD1-46D8-A09F-34A2CE42DCDDQ33588353-A4E09636-57A5-4424-8F00-36A6F5871837Q33596451-0EBF56AB-A01C-4BED-A17E-625E7CB5BD7CQ33675743-A0336688-53B1-4A70-B71D-B532CE0A3DC1Q33758428-6EA65D62-C91C-49B2-BFA1-7DF62FAD4C41Q33959166-0CB2EB2F-FB1A-488F-8129-2722385A04FEQ34013606-2F870DD3-EA33-4D49-A831-7EB46A49BBF0Q34743671-A0195145-49A3-4E64-9CDE-E3AF0463277EQ35009309-929545E6-4EBB-46C2-81C8-00FB28CD7153Q35060322-03916018-3F76-44AE-BF27-93FA5E38540FQ35195486-4E023E51-1EBD-4EED-A95D-435323AB9FF4Q35195973-5D4FEDB8-00ED-4482-BF56-5A09B601CB63Q35389546-67350954-A43A-4A23-9C3B-EFF22035D087Q35434364-5FEFCB08-6AED-4164-BCE0-DCBC708D2931Q35487636-FD852557-B70D-4CEE-9C72-18FE252DE338Q35648122-4EEB8389-BF0B-4BE8-A177-9BD2E1E99641Q35882484-6F77E99F-29A6-4280-AB08-56C92AAA2A8EQ36576947-C0721421-F86D-42F6-BB03-87A30E43AA34Q37070395-33C4A0B1-E66D-496D-A635-7F873E877FF3Q37271770-41269865-1D69-4E14-97F7-D54598E596BEQ37285146-654F1F56-F664-44FB-9920-1EB59743CA93Q38957083-056B3A91-88E9-4D4A-B3A9-838AE60DED93Q39171367-DADB061F-F5FF-4A23-8B37-BBE0CC9AA4CFQ41478676-5439C5EC-572F-4696-968D-2CCE7976A0A2Q42139634-3ED5FF78-2517-4D53-8394-3F22C85EE606Q42659272-3223B230-0515-4276-9300-D45EA20DFF4EQ48190297-64F37896-A5D9-452C-9506-64A21E2104FC
P2860
DNA mutation associated with the human butyrylcholinesterase K-variant and its linkage to the atypical variant mutation and other polymorphic sites
description
1992 nî lūn-bûn
@nan
1992 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
DNA mutation associated with t ...... on and other polymorphic sites
@ast
DNA mutation associated with t ...... on and other polymorphic sites
@en
type
label
DNA mutation associated with t ...... on and other polymorphic sites
@ast
DNA mutation associated with t ...... on and other polymorphic sites
@en
prefLabel
DNA mutation associated with t ...... on and other polymorphic sites
@ast
DNA mutation associated with t ...... on and other polymorphic sites
@en
P2093
P2860
P1476
DNA mutation associated with t ...... on and other polymorphic sites
@en
P2093
A F van der Spek
C F Bartels
F S Jensen
H M Rubinstein
O Lockridge
P2860
P304
P407
P577
1992-05-01T00:00:00Z